CBLN1 and Alzheimer disease: Studies of individual subclasses of ceramides have reported similar findings, with the skin of infants who later develop AD showing upregulation of short 16oC acyl chains compared to controls [54, 55], which concurs with the assessment of CER[NdS] observed here.